Pipeline Progress Update News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(2)
NEW YORK CITY (dpa-AFX) - Today s Daily Dose brings you news about Lexicon s regulatory update on Sotagliflozin in heart failure; FDA approval of Pfizer s XALKORI in a new indication; Bicycle s pipeline progress update and Organogenesis progress in knee osteoarthritis trial.
Read on.
1. Bicycle Rides High on Pipeline Progress Update
Shares of Bicycle Therapeutics plc (BCYC) touched a new high on Thursday on the back of its pipeline progress update.
The company s lead drug candidate BT1718 is progressing in the phase IIa portion of the Cancer Research UK sponsored phase I/IIa clinical trial in patients with advanced solid tumors. Enrollment in two solid tumor cohorts, one in squamous non-small cell lung cancer (NSCLC) and the other in an all-comers basket cohort is ongoing at four clinical sites, with additional sites expected to begin enrolling patients during the first half of 2021. ....

United States , United Kingdom , Organogenesis Holdings Inc , Bionano Genomics Inc , Ocugen Inc , Lexicon Pharmaceuticals Inc , Viveve Medical Inc , Generation Bio Co , Calithera Biosciences Inc , Pfizer Inc , Cancer Research United Kingdom , Daily Dose , Rides High , Pipeline Progress Update , Bicycle Therapeutics , Lexicon Pharmaceuticals , New Drug Application , Forges Ahead , Western Ontario , Mcmaster Universities Osteoarthritis Index , Approved Use , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , அகராதி மருந்துகள் இன்க் , ஜெநரேஶந் உயிர் இணை , ஃபைசர் இன்க் ,